21247 Results

People

  1. Brennan
    Brennan
  2. Jarnagin
    Jarnagin
  3. Abu-Rustum
    Abu-Rustum
  4. Rusch
    Rusch
  5. D'Angelica
    D'Angelica
  6. Fong
    Fong
  7. Morrow
    Morrow
  8. Shah
    Shah
  9. Chi
    Chi
  10. Shaha
    Shaha

Groups

  1. Surgery (21247)
  2. Survivorship Research (5130)
  3. Department of Medicine (4873)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4018)
  6. Epidemiology and Biostatistics (3680)
  7. Department of Pathology and Laboratory Medicine (3639)
  8. Center for Pancreatic Cancer Research (3115)
  9. Population Sciences Research Program (2966)
  10. GSK Faculty (2773)
  1. "Surgery"
Formats
  1. Journal Article (13274)
  2. Meeting Abstract (4871)
  3. Book Section (1145)
  4. Review (581)
  5. Editorial (559)
  6. Conference Paper (249)
  7. Correspondence (151)
  8. Miscellaneous (141)
  9. Guidelines (125)
  10. Book Whole (91)
  11. Research Letter (60)
Groups
  1. Surgery (21247)
  2. Survivorship Research (5130)
  3. Department of Medicine (4873)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4018)
  6. Epidemiology and Biostatistics (3680)

More Groups

People
  1. Murray Brennan (1059)
  2. William Jarnagin (903)
  3. Nadeem Abu-Rustum (888)
  4. Valerie Rusch (864)
  5. Michael D'Angelica (777)
  6. Yuman Fong (775)

More People

Years
  1. 2025 (375)
  2. 2024 (984)
  3. 2023 (930)
  4. 2022 (1036)
  5. 2021 (954)
  6. 2020 (919)

More Years

Publications
  1. Journal of Clinical Oncology (1551)
  2. Annals of Surgical Oncology (1512)
  3. Gynecologic Oncology (874)
  4. Journal of Urology (548)
  5. International Journal of Radiation Oncology, Biology, Physics (458)
  6. Cancer (424)

More Publications

Publishers
  1. Elsevier Inc. (3546)
  2. Springer (2678)
  3. Elsevier Science, Inc. (2049)
  4. Lippincott Williams & Wilkins (1663)
  5. American Society of Clinical Oncology (1644)
  6. Wiley Blackwell (1224)

More Publishers

Results (21247)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pexidartinib for advanced tenosynovial giant cell tumor (TGCT): Long-term efficacy and safety from the phase 3 ENLIVEN and phase 1 PLX108-01 (TGCT cohort) studies
    Meeting Abstract

    Gelderblom, H.; Tap, W. D.; Palmerini, E.; Stacchiotti, S.; Wainberg, Z. A.; Desai, J.; Healey, J. H.; van de Sande, M.; Bernthal, N. M.; Peterfy, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Association of body mass index (BMI) with clinical outcomes in 203 metastatic clear cell renal cell carcinoma (ccRCC) patients (pts) treated with immuno-oncology (IO) agents
    Meeting Abstract

    Ged, Y.; Lee, C. H.; Sanchez, A.; Duzgol, C.; Chaim, J.; Carlo, M. I.; Foster, A.; Akin, O.; Feldman, D. R.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Decreasing postoperative opioid prescriptions in ambulatory extended recovery patients
    Meeting Abstract

    Fearon, N.; Chesnut, G. T.; Benfante, N.; Assel, M.; Mauzoul, S.; Levine, M.; Broach, V.; Vickers, A.; Eastham, J. A.; Twersky, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Factors associated with one-year mortality after debulking surgery in older women with ovarian cancer
    Meeting Abstract

    Filippova, O. T.; Tew, W. P.; O'Cearbhaill, R. E.; Sonoda, Y.; Long-Roche, K. C.; Zivanovic, O.; Gardner, G. J.; Chi, D.; Shahrokni, A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • CALGB 90203 (Alliance): Radical prostatectomy (RP) with or without neoadjuvant chemohormonal therapy (CHT) in men with clinically localized, high-risk prostate cancer (CLHRPC)
    Meeting Abstract

    Eastham, J. A.; Heller, G.; Halabi, S.; Monk, P.; Clinton, S. K.; Szmulewitz, R. Z.; Coleman, J.; Gleave, M.; Evans, C. P.; Hillman, D. W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes of men with prostate cancer managed with active surveillance and tested with clinical cell-cycle risk score
    Meeting Abstract

    Ehdaie, B.; Kaul, S.; Wojno, K.; Evans, B.; Bernhisel, R.; Meek, S.; D'Anna, R.; Ferguson, J.; Glaser, J.; Morgan, T. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma
    Meeting Abstract

    Dickson, M. A.; Koff, A.; D'Angelo, S. P.; Gounder, M. M.; Keohan, M. L.; Kelly, C. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Validation of a panel of risk factors for predicting breast cancer reappearance
    Meeting Abstract

    Corso, G.; Veronesi, P.; Maisonneuve, P.; Goldhirsch, A.; Sacchini, V.; Caldarella, P.; De Scalzi, A. M.; Galimberti, V.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Preoperative checkpoint inhibition (CPI) and cryoablation (Cryo) in women with early-stage breast cancer (ESBC)
    Meeting Abstract

    Comen, E. A.; Bryce, Y.; Page, D. B.; Solomon, S. B.; Rodine, M.; Abaya, C. D.; Morris, E. A.; Plitas, G.; El-Tamer, M.; Gemignani, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Cell cycle progression score differentiates indolent from aggressive prostate cancer in men diagnosed by TURP
    Meeting Abstract

    Cuzick, J. M.; Stone, S.; Rajamani, S.; Moller, H.; Berney, D. M.; Cohen, T.; Scardino, P. T.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save